Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.68%, near the low end of its 5-year range (0.00%–95.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 19.14%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
19.14%
DEBT TO ASSETS RATIO AVG 3Y
0.83%
DEBT TO ASSETS RATIO AVG 5Y
0.68%
DEBT TO ASSETS RATIO AVG 10Y
0.65%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Indaptus Therapeutics, Inc.
Market Cap
$274.61M
Debt to Assets Ratio
0.00%
TTM Avg
19.14%
3Y Avg
0.83%
5Y Avg
0.68%
Market Cap
$274.71M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$272.17M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.84M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.92M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$284.38M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.16M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$286.20M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | $274.61M | 0.00% | 19.14% | 0.83% | 0.68% |
| Aurora Cannabis Inc. (ACB)vs › | $274.71M | 0.04% | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $272.17M | 0.29% | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $281.84M | 0.11% | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | 0.02% | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $284.38M | 0.01% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.16M | 0.01% | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $286.20M | 0.03% | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $259.91M | 0.10% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
19.48
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.13% |
| 2025-06-30 | 95.58% |
| 2025-03-31 | 1.10% |
| 2024-12-31 | 1.15% |
| 2024-09-30 | 1.31% |
| 2024-06-30 | 1.61% |
| 2024-03-31 | 1.40% |
| 2023-12-31 | 1.17% |
| 2023-09-30 | 1.10% |
| 2023-06-30 | 1.04% |
| 2023-03-31 | 1.02% |
| 2022-12-31 | 0.29% |
| 2022-09-30 | 0.34% |
| 2022-06-30 | 0.37% |
| 2022-03-31 | 0.40% |
| 2021-12-31 | 0.42% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 3.14% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 4.23% |
| 2020-06-30 | 4.90% |
| 2020-03-31 | 5.67% |
| 2019-12-31 | 6.31% |
| 2019-09-30 | 2.15% |
| 2019-06-30 | 1.38% |
| 2019-03-31 | 1.15% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
